Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy2件: Bezafibrate,
Ursodeoxycholic acid (UDCA)		2件: Ursodiol ,
Bezafibrate 💬		2件: NR1H4,
PPARA 💬		11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 94 💬
2Standard of Care: UDCA1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
3UDCA1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬6件: 46, 67, 93, 94, 97, 296 💬
4UDCA (Ursodeoxycholic acid)1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 93 💬
5Ursodeoxycholic acid (UDCA)1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 94 💬
6Ursodeoxycholic acid (UDCA) 500 mg1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 46 💬
7Ursodiol (ursodeoxycholic acid, UDCA)1件: Ursodeoxycholic acid (UDCA)1件: Ursodiol 💬1件: NR1H4 💬1件: Bile secretion 💬1件: 97 💬